STAT+: FDA approves novel Bayer drug to reduce recurrence of stroke

AI Summary

The US Food and Drug Administration approved a Bayer drug intended to reduce the risk of recurrent stroke. The medication belongs to a novel class designed to prevent blood clots without increasing bleeding risk.

Bayer's drug is the first in a novel class of medications designed to prevent blood clots without increasing risk of bleeding.